APLI:CC News and Press, Appili Therapeutics Inc. From 10/01/25

Awarded contract base period of US$3.6 million to fund vaccine manufacturing with additional option periods to advance development through Phase 1 trials Submitted up to US$97 million in additional U.S. government funding proposals HALIFAX, Nova Scotia, Oct. 01, 2025 (GLOBE NEWSWIRE...

HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the re...

A look at the top 10 most actives in Canada Bitfarms Ltd. (BITF) rose 9.4% to $2.68 on volume of 4,932,389 shares Pembina Pipeline Corporation (PPL) fell 0.5% to $53.445 on volume of 2,353,159 shares BMO Equal Weight Banks Index ETF (ZEB) rose 0.1% to $51.04 on volume of 2,324,894 shares ...

HALIFAX, Nova Scotia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that Carl Gelhaus,...

Submitted two additional U.S. government funding proposals during the quarter, bringing the total proposals to US$137 million Accepted as a new member of U.S. Medical CBRN Defense Consortium, strengthening government and biodefense partnerships HALIFAX, Nova Scotia, Aug. 14, 202...

Magellan Aerospace Corporation (MAL:CA) is expected to report for Q2 2025 TeraGo Inc. (TGO:CA) is expected to report for Q2 2025 Touchstone Exploration Inc. (TXP:CA) is expected to report for Q2 2025 True North Commercial Real Estate Investment Trust (TNT.UN:CA) is expected to report ...

Peer-reviewed publication highlights ATI-1701’s robust protection against aerosolized Francisella tularensis exposure in multiple animal models HALIFAX, Nova Scotia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or ...

2025-07-24 09:35:00 ET Aditxt (NASDAQ: ADTX) , a social innovation platform advancing health technologies, announced that its subsidiary Pearsanta, Inc. has been invited to submit a full proposal for the U.S. Department of Defense’s OCRP Pilot Award. The proposal supports Pearsan...

2025-07-22 09:35:00 ET Aditxt (NASDAQ: ADTX) , a social innovation platform advancing health solutions, will host a livestream on July 22, 2025, at 1:00 p.m. ET to highlight its autoimmune therapeutics subsidiary, Adimune Inc. The event, hosted by Jack Marks of Wall Street Reporter, wil...

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals submitted, totalling up to US$125 million HALIFAX, Nova Scotia, June 25, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTC...